The Aentib Group
The Aentib Group
  • Home
  • About
    • Values
    • History
    • Team
    • Press
    • Careers
    • Contact
  • For Companies
    • Our Process
    • Aentib Advantage
    • Success Stories
  • For Investors
    • Private Placement Advisory
    • Customized Deal Sourcing
    • New Product Development
    • Strategic Due Diligence
    • Access Canada Program
    • Success Stories
  • Aentib Ventures
    • Healthcare / Biotech >
      • NovoSilio Therapeutics
      • Impact BioChem
    • Technology
  • Blog
  • Home
  • About
    • Values
    • History
    • Team
    • Press
    • Careers
    • Contact
  • For Companies
    • Our Process
    • Aentib Advantage
    • Success Stories
  • For Investors
    • Private Placement Advisory
    • Customized Deal Sourcing
    • New Product Development
    • Strategic Due Diligence
    • Access Canada Program
    • Success Stories
  • Aentib Ventures
    • Healthcare / Biotech >
      • NovoSilio Therapeutics
      • Impact BioChem
    • Technology
  • Blog

a track record we are proud of

Just a small sample of recent wins...

Picture
ConforMIS is a privately held medical device company pioneering patient-specific orthopedic implants. In 2013, Aentib advised on ConforMIS’ series E financing round of $167.7M. Investors include: Top-tier Sovereign Wealth Funds, Government Investment Funds and Private Equity Funds in North America, Europe, Asia and the Middle East. 


Picture
Obalon Therapeutics Inc. is a California-based developer of a balloon-based weight loss device. Aentib advised Obalon on its $20 million, Series D funding round. Investors include both strategics and institutions. 

Picture
Argos Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases. Aentib Group advised Argos Therapeutics on its $60M financing.
© 2015 Aentib Group. All Rights Reserved. 630 René-Lévèsque, Montréal, Canada
Subscribe to our newsletter
Picture
✕